7-23-17 WEEKEND REPORT: Updates, Promos and More!

Hope everyone enjoyed their weekend and are excited for Monday’s opening bell. In my article, I will update readers on previously mentioned companies, take a peek at what closed well on Friday, and check my emails to see what the email newsletters are promoting for Monday.

Let’s start with $OMVS (On the Move Systems) as this one is quite popular. Some readers may roll their eyes and wonder why this stock gets so much attention, the answer is simple. When and if you have a company with a chart like this (see below) I will be more than happy to talk about it too!

So where are we with $OMVS? 10Q is coming, maybe even Monday morning. Friday (RAD ceo) Steve tweeted that he will be ready for early August. He has been meeting with OMVS Ceo Garrett, posting pics with smiles and working on business. The deal is going through, no doubt in my mind (all my opinion lol)… I don’t think it will be announced in July, but early August. Remember, the deadline is 8-11-2017. Here is a great due diligence link on $OMVS is you wish to learn more.–> https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133227868

Many have been hyping that  $OMVS should be a $1+ stock in a year, yada yada yada… and I roll my eyes. I have seen fluff, hype, cheer-leading or whatever you want to call it before, but… I’m starting to think it could be a possibility. When skimming through the DD link above, you can see that RAD has a bunch of prototypes already designed. They are not at the business stage where they are like, “hey…we have an idea to make a security robot”. The company is ready, it has been doing trade shows and roadshows and as much as pres releases have talked about other California relationships… this is bigger than Cali, or the USA, as security is a global need. They are positioned to take orders now! As long as they can keep the outstanding share count under 50 million or so and not have to dilute to raise financing to manufacture product, they are in great shape. Contracts are key, revenues are important and the more companies that are willing to take a progressive approach to bots over human security guards, it allows for amazing growth potential. The merger anticipation and possible early contracts make OMVS a good short term play, and the growth allow it to be a solid long term play as well.

$CCLX (CableClix) we alerted grabbing some at $0.017 this month and it closed Friday at (0.0285/0.0288). I like this cable/ISP related sector, as $OTTV was at one point a gainer of 2500%+, yet other companies in the sector priced accordingly “saw little to no love”. That is changing as CCLX looks to be in accumulation mode, volume is solid and continues to trade multiples of its 30 day average. Low float, NEWS, continued pressure will all help bust this one over a dime soon. (again in my opinion)

$RIHT (RightsCorp.) we alerted at .04, is now higher .04’s almost .05 – Like CCLX, it also is in accumulation mode in the Cable ISP sector, yet they are producing revenues through fines from copy right infringements. This is a monster global market for any individual or company looking to protect the “pirating” of their intellectual property, whether the content is music or video. Last weekend’s report we spoke of the expansion globally with their presence in Israel… this past week’s PR now also has them involved with South Africa. The more countries, the more content they protect, the more revenues the company will make. At the end of last year, the company was in danger of closing its doors. After winning a lawsuit against ISP giant COX Communications, it is not only positioned to keeps its doors open, but become a revenue generating machine with high profit margins. The company has a 52 week low of .015, and at one point was a $2 stock when they announced the same business model. Things are at its brightest now for the company, yet it’s only about (.05). Like OMVS, another company that has both short term and long term potential.

$OTTV, eased on Friday (.0023), but am still bullish on this company. I like the sector as stated earlier and the fact it has pulled back from it’s recent high of .009, plus knowing the note holders are not converting for 60 days, allowing the company to breathe.


Now looking at Friday’s gainers (pink sheets not included)

eWellness Healthcare Corp ($EWLL) 0.1750 +.053 (43.44%) on volume of 2,809,899.

A Friday News Release may have fanned this plan–>

CULVER CITY, CA–(Marketwired – Jul 21, 2017) – eWellness Healthcare Corporation — (OTCQB: EWLL) — a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has signed a Letter of Intent Agreement between US Health Center, Inc. (“USHC”) and an undisclosed US healthcare provider. Between both USHC and the undisclosed US healthcare payer group they anticipate having approximately 100,000 healthcare insured customers by the end of 2017. The Parties to this LOI have agreed to use their best efforts to conclude Definitive Agreements between the Parties over the next 90 days. According to eWellness, these new agreements (if executed) are anticipated to generate initially up to $4.2 million in annual reoccurring gross revenue for the Company. This level of sales is anticipated to allow the Company to gain cash flow positive operations during the latter part of 2017.


So far, here are 3 companies promoters/newsletters are talking about.

Magellan Gold Corporation ($MAGE) is a U.S. based mining and exploration company, with a primary focus on silver and gold.

PetLife Pharmaceuticals, Inc. ($PTLF) is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology.

Telecorp, Inc. ($TLNUF) is an North American emerging technology company headquartered in New York, NY. with operations in over six countries.

 

Disclosure: PSInvestor has NOT been compensated to mention any of the above companies. We are long CCLX bought on the open market.

Be the first to comment

Leave a Reply

Your email address will not be published.


*